New risk score could predict strokes in heart patients despite blood thinners

NCT ID NCT07713537

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study aims to create a better way to predict stroke risk in people with atrial fibrillation (an irregular heartbeat) who are already taking direct oral anticoagulants (DOACs), a type of blood thinner. Even with these medications, some patients still have strokes. Researchers will analyze data from 250 patients to design a risk scale that includes clinical, demographic, and other factors. The goal is to identify who remains at high risk so doctors can tailor treatment more effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a better tool to predict stroke risk in atrial fibrillation patients taking blood thinners, potentially preventing strokes.
What could go wrong
This is an observational study to develop a risk scale, not a treatment trial. The scale may not prove accurate enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Germans Trias University Hospital

    RECRUITING

    Barcelona, Barcelona, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Vall d'Hebron University Hospital

    RECRUITING

    Barcelona, Barcelona, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.